Access

Article


Nature Medicine 13, 1349 - 1358 (2007)
Published online: 4 November 2007 | doi:10.1038/nm1667

Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis

Berend Isermann1,10, Ilya A Vinnikov1,10, Thati Madhusudhan1,10, Stefanie Herzog1, Muhammed Kashif1, Janusch Blautzik1, Marcus A F Corat2,9, Martin Zeier3, Erwin Blessing4, Jun Oh5, Bruce Gerlitz6, David T Berg6, Brian W Grinnell6, Triantafyllos Chavakis7, Charles T Esmon8, Hartmut Weiler2, Angelika Bierhaus1 & Peter P Nawroth1


Data providing direct evidence for a causative link between endothelial dysfunction, microvascular disease and diabetic end-organ damage are scarce. Here we show that activated protein C (APC) formation, which is regulated by endothelial thrombomodulin, is reduced in diabetic mice and causally linked to nephropathy. Thrombomodulin-dependent APC formation mediates cytoprotection in diabetic nephropathy by inhibiting glomerular apoptosis. APC prevents glucose-induced apoptosis in endothelial cells and podocytes, the cellular components of the glomerular filtration barrier. APC modulates the mitochondrial apoptosis pathway via the protease-activated receptor PAR-1 and the endothelial protein C receptor EPCR in glucose-stressed cells. These experiments establish a new pathway, in which hyperglycemia impairs endothelial thrombomodulin-dependent APC formation. Loss of thrombomodulin-dependent APC formation interrupts cross-talk between the vascular compartment and podocytes, causing glomerular apoptosis and diabetic nephropathy. Conversely, maintaining high APC levels during long-term diabetes protects against diabetic nephropathy.


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Preventing kidney cell suicide

Nature Medicine News and Views (01 Nov 2007)

PAR1 signaling: more good than harm?

Nature Medicine News and Views (01 Mar 2003)

See all 4 matches for News And Views